According to previous studies, TUG1 was found to be upregulated and oncogenic in a broad spectrum of cancers, including colorectal cancer, bladder cancer, esophageal squamous cell carcinoma, and osteosarcoma [4–7]. This evidence concerns the gene TUG1 and urinary bladder cancer.